Are you Dr. Petrich?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
676 N Saint Clair St
Ste 2100
Chicago, IL 60611Phone+1 312-695-6180Fax+1 312-695-4770
Summary
- Dr. Adam Petrich, MD is an oncologist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois. He is an Assistant Professor in Medicine-Hematology/Oncology at Northwestern University Medical School.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2008 - 2011
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2005 - 2008
University of Illinois College of MedicineClass of 2005
Certifications & Licensure
IL State Medical License 2011 - 2017
Clinical Trials
- Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Start of enrollment: 2010 Apr 15
- Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers Start of enrollment: 2012 Feb 27
- Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Start of enrollment: 2015 Jun 11
- Join now to see all
Publications & Presentations
PubMed
- A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen.Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter
Blood Advances. 2024-04-09 - Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage development.Yasong Lu, Shuang Liang, Ying Hong, Naoyuki Tajima, Kashyap Patel
CPT. 2024-01-01 - 4 citationsIbrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.Reem Karmali, Jeremy S Abramson, Deborah M Stephens, Jeffrey Barnes, Jane N Winter
Blood Advances. 2023-12-12
